- Home
- PSHG vs GNTA Comparison
PSHG vs GNTA Comparison
Compare PSHG & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.92
HOLD
Current Price
$0.70
Company Overview
Basic Information| Metric | PSHG | GNTA |
|---|---|---|
| Founded | 2010 | 2014 |
| Country | Greece | Italy |
| Employees | N/A | 13 |
| Industry | Marine Transportation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.7M | 19.9M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | PSHG | GNTA |
|---|---|---|
| Price | $1.92 | $0.70 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 187.2K | 65.1K |
| Earning Date | 03-04-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $49.57 | N/A |
| Revenue Next Year | $4.76 | N/A |
| P/E Ratio | $1.59 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.31 | $0.59 |
| 52 Week High | $2.58 | $10.00 |
Technical Indicators
Market Signals| Indicator | PSHG | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 44.30 | 40.05 |
| Support Level | $1.77 | $0.59 |
| Resistance Level | $2.06 | $1.70 |
| Average True Range (ATR) | 0.14 | 0.11 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 29.84 | 28.20 |
Price Performance
Historical Comparison PSHG
GNTA
About PSHG Performance Shipping Inc.
Performance Shipping Inc is a provider of shipping transportation services through its ownership of tanker vessels. The company's vessels are employed on time charters with liner companies carrying containerized cargo along various shipping routes. It owns and operates six Aframax tanker vessels.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.